Background: More than half of intravenous drug users (IDUs) in China suffer from the Hepatitis C virus (HCV). The virus is also more prevalent in non-injection drug users (NIDUs) than in the general population. However, not much is known about HCV subtype distribution in these populations.
Methods: Our research team conducted a cross-sectional study in four provinces in China. We sampled 825 IDUs and 244 NIDUs (1162 total), genotyped each DU's virus, and performed a phylogenetic analysis to differentiate HCV subtypes.
Results: Nucleic acid testing (NAT) determined that 82% percent (952/1162) of samples were HCV positive; we subtyped 90% (859/952) of these. We found multiple HCV subtypes: 3b (249, 29.0%), 3a (225, 26.2%), 6a (156, 18.2%), 1b (137, 15.9%), 6n (50, 5.9%), 1a (27, 3.1%), and 2a (15, 1.7%). An analysis of subtype distributions adjusted for province found statistically significant differences between HCV subtypes in IDUs and NIDUs.
Discussion: HCV subtypes 3b, 3a, 6a, and 1b were the most common in our study, together accounting for 89% of infections. The subtype distribution differences we found between IDUs and NIDUs suggested that sharing syringes was not the most likely pathway for HCV transmission in NIDUs. However, further studies are needed to elucidate how NIDUs were infected.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4605846 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140263 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Characterization of Incident Hepatitis C Virus Infection among People Living with HIV in a HIV Clinic in Korea.
Infect Chemother
December 2024
Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Medical Center, Seoul, Korea.
Background: Coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) can cause more rapid progression to cirrhosis than HCV-monoinfection. In this study, incident HCV case (IHCV)s were investigated in a HIV clinic in Korea.
Materials And Methods: A retrospective HIV cohort was constructed who visited National Medical Center in Korea from 2013 to 2022 and performed ≥ 1 anti-HCV antibody tests (anti-HCV) during the study period.
Global Origin and Spatiotemporal Spread of Hepatitis C Virus Epidemic Genotypes/Subtypes: A Complete Genome-Based Phylodynamic and Phylogeographic Analyses.
J Med Virol
December 2024
Virology Unit and Bioinformatics Centre, Institute of Microbial Technology (IMTECH), Council of Scientific and Industrial Research (CSIR), Chandigarh, India.
Hepatitis C virus (HCV) is a pathogenic virus of global health concern. The phylodynamics of HCV genotypes/subtypes 1a, 1b, 2, and 3 are explored only for specific geographic regions. However, their genome based global origin and detailed spatiotemporal spread, have yet to be extensively studied.
View Article and Find Full Text PDFPrevalence and drug resistance analysis of hepatitis C virus genotypes in Heilongjiang, China.
Infect Genet Evol
January 2025
Scientific Research Center, The Second Affiliated Hospital of Harbin Medical University, Harbin 150000, Heilongjiang, China. Electronic address:
Hepatitis C still poses a threat to public safety, and there are few reports of hepatitis C virus (HCV) in Heilongjiang Province. Therefore, we aimed to study the epidemiology and resistance-associated substitutions (RASs) of HCV in Heilongjiang and explore the efficacy of treatment. 7019 specimens from Heilongjiang Province were subjected to the genotype identification.
View Article and Find Full Text PDFGeneration of Optimized Consensus Sequences for Hepatitis C virus (HCV) Envelope 2 Glycoprotein (E2) by a Modified Algorithm: Implication for a Pan-genomic HCV Vaccine.
Avicenna J Med Biotechnol
January 2024
Department of Molecular Virology, Pasteur Institute of Iran, Tehran, Iran.
Article Synopsis
- - The development of a vaccine for Hepatitis C Virus (HCV) is essential despite the effectiveness of existing treatments, particularly focusing on inducing Pangenomic neutralizing Antibodies (PnAbs) against the diverse HCV Envelope 2 protein.
- - Current algorithms for creating Consensus Sequences (CS) face challenges such as rigidity and insensitivity to evolutionary changes, prompting researchers to modify the "Majority" algorithm with BLOSUM matrices and assess it against the "Fitness" algorithm.
- - The "Fitness" algorithm outperformed others by producing well-defined HCVE2 sequences for all HCV genotypes, considering evolutionary factors and offering improved properties for vaccine development, suggesting its applicability for other variable pathogens as well. *
One-step, rapid, nanoparticle-based biosensor platform for the simultaneous identification of hepatitis B virus and hepatitis C virus in clinical applications.
BMC Microbiol
November 2024
The Second Clinical Medical College, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou, 550003, People's Republic of China.
Article Synopsis
- Viral hepatitis from HBV and HCV is a significant global health issue, especially in low- and middle-income countries, making effective point-of-care testing essential.
- A new diagnostic test, mLAMP-AuNPs-LFB, was developed for quick and accurate detection of both HBV and HCV using advanced molecular techniques and a simple visual readout.
- The test demonstrated a rapid process taking about 50 minutes with high sensitivity (detecting as low as 20 copies of the virus) and 100% specificity against other pathogens, reinforcing its potential for clinical use.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!